Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
RNA · against 176 other Healthcare companies of similar size
Ranked #23 of 177 · scores higher than 88% of peers · safety percentile 91
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)26 peers with a safety percentile of 90–100, including RNA · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | RNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 159 reported | 0.01× | 0.21× | 91% | 33% | |
| BetaLower is better · 169 reported | Not reported | 0.61 | — | — | 33% |
| Current ratioHigher is better · 173 reported | 8.73× | 2.85× | 81% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 186M USD | 100 | 52 | |
| 2 | 165M USD | 99 | 50 | |
| 3 | 261M USD | 99 | 97 | |
| 4 | 284M AUD (≈$188M) | 98 | 36 | |
| 5 | 213M USD | 98 | ||
| 18 | 256M USD | 94 | 80 | |
| 20 | 184M USD | 92 | 33 | |
| 21 | 109M USD | 92 | 47 | |
| 22 | 8.1B TWD (≈$251M) | 92 | 69 | |
| 23 | 149M USD | 91 | ||
| 24 | 285M USD | 91 | 38 | |
| 25 | 205M USD | 91 | 36 | |
| 26 | 3.4B TWD (≈$106M) | 90 | 36 | |
| 27 | 255M USD | 89 | 38 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score